We had previously tested MUC1 peptide vaccines composed of the cancer-specific core peptide antigen consisting of 5 copies of the unglycosylated 20mer tandem repeat sequence from the VNTR region, combined with different adjuvants. This evidence concerns the gene MUC1 and cancer.